SANGMYUNG innovation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular Edema (NCT07708142) | SANGMYUNG innovation | 2026-01-29 |
| Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy (NCT07695207) | SANGMYUNG innovation | 2025-09-15 |
Track SANGMYUNG innovation automatically
Every clearance here is in the API, with alerts when new ones post.